Brief: Emerald Bioscience Announces Notice Of Allowance From United States Patent Office For Proprietary Analog Of Cannabidiol
09/03/2020 13:39
March 9 (Reuters) - Emerald Bioscience Inc EMBI.PK :
* EMERALD BIOSCIENCE ANNOUNCES NOTICE OF ALLOWANCE FROM
UNITED
STATES PATENT OFFICE FOR PROPRIETARY ANALOG OF CANNABIDIOL
Source text for Eikon: ID:nGNX7hg2b0
Further company coverage: EMBI.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsBrief: Skye Announces Cohort Review Committee Approved Opening Of Cohort 2 Based On Favorable Safety Data From First Four Participants Treated In Cohort 1
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Skye Bioscience rises as it begins testing higher doses of obesity drug